Voyager Therapeutics, Inc.
Biotechnology company · Lexington, Massachusetts, United States · Nasdaq: VYGR
Voyager Therapeutics, Inc. is a biotechnology company headquartered in Lexington, Massachusetts, United States. Its earliest recorded incorporation is in 2013. Its shares trade on Nasdaq under the ticker VYGR. It has reported private securities offerings to the US SEC, most recently $20 million sold in a notice filed in 2024.
Voyager Therapeutics at a glance
What does Voyager Therapeutics do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $20 million sold (2024).
Frequently asked questions about Voyager Therapeutics
Where is Voyager Therapeutics headquartered?
Voyager Therapeutics, Inc. is headquartered in Lexington, Massachusetts, United States.
What does Voyager Therapeutics do?
Voyager Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Voyager Therapeutics a public company?
Yes. Voyager Therapeutics, Inc. trades on Nasdaq under the ticker VYGR.
When was Voyager Therapeutics founded?
The earliest incorporation on record for Voyager Therapeutics, Inc. is in 2013, according to public company registers.
Similar companies
- Agenus IncLexington, Massachusetts, United States
- Curis IncLexington, Massachusetts, United States
- Biomedical Development CorpLexington, Kentucky, United States
- Translate Bio, Inc.Lexington, Massachusetts, United States
- LogicBio Therapeutics, Inc.Lexington, Massachusetts, United States
- Oasis Pharmaceuticals, LLCLexington, Massachusetts, United States
- LayerBio, Inc.Lexington, Massachusetts, United States
- Hera Testing Laboratories, Inc.Lexington, Kentucky, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-24. Data licences